Medical composition containing <i>Stauntonia hexaphylla </i>extract

摘要

Disclosed is an antipyretic drug comprising a Stauntonia Hexaphylla leaf extract as an active ingredient. The antipyretic drug is developed based on the finding that the Stauntonia Hexaphylla leaf extract has no cytotoxicity and exhibits superior antipyretic effects, as compared to conventional antipyretic drugs having antipyretic effects. An antipyretic composition comprising the Stauntonia Hexaphylla leaf extract as an active ingredient exhibits potent antipyretic effect.

主权项

1. An anti-inflammatory composition, comprising:
a Stauntonia Hexaphylla fraction as an active ingredient that is made by extracting Stauntonia Hexaphylla leaf by boiling in water at 100° C. for 3 hours, separating into hexane soluble and insoluble layer, and using chloroform or ethyl acetate to fractionate the hexane insoluble layer; and a pharmaceutically acceptable carrier.